We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 07, 2020

Benefit of Dual Corticosteroids and IVIg in Kawasaki Disease

Journal of the American Heart Association

 

Additional Info

Journal of the American Heart Association
Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High-Risk Patients With Kawasaki Disease
J Am Heart Assoc 2020 Aug 19;[EPub Ahead of Print], R Ae, JY Abrams, RA Maddox, LB Schonberger, Y Nakamura, M Kuwabara, N Makino, Y Matsubara, K Kosami, T Sasahara, ED Belay

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading